Liraglutide or semaglutide? The Honest Side-by-Side Comparison

Liraglutide at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2010
• Route: subcutaneous injection
• Typical frequency: once daily
• Half-life: approximately 13 hours
• Cash price (US): $1,200-$1,400/month without insurance
• Receptor target: GLP-1 receptor

Head-to-head comparisons in this space are useful but easy to overweight. The truth is that most differences shake out to a couple of percentage points of efficacy and a different side-effect distribution. Here's how the two compare.

Mechanism

Liraglutide: Liraglutide is a once-daily GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1. It slows gastric emptying, increases satiety through receptors in the hypothalamus, and stimulates glucose-dependent insulin secretion from pancreatic beta cells.

semaglutide: GLP-1 receptor agonists mimic the natural incretin hormone glucagon-like peptide-1. They slow gastric emptying, increase satiety, and stimulate glucose-dependent insulin secretion.

For people new to this comparison, the practical takeaway is that both work through similar pathways but have different pharmacokinetics.

Dosing & Administration

Effectiveness

Liraglutide: Average weight loss of 5-8% of body weight at one year in clinical trials, with additional A1c reductions of 1.0-1.5% in people with type 2 diabetes.

semaglutide: Reduced appetite, weight loss, and improved glycemic control.

In head-to-head comparisons (where they exist), the higher-dose newer agents tend to outperform older ones — sometimes meaningfully. Reference trials: SCALE Obesity and Prediabetes trial (Pi-Sunyer 2015, NEJM) — 9 for Liraglutide; STEP 1 (Wilding 2021), SURMOUNT-1 (Jastreboff 2022), SUSTAIN-6, REWIND for semaglutide.

Side Effects

The two compounds have overlapping side-effect profiles. Common to both:

• nausea
• diarrhea
• constipation
• vomiting
• headache
• injection-site reactions

Important risks worth knowing for both:

• pancreatitis
• gallbladder disease
• thyroid C-cell tumors (boxed warning)
• acute kidney injury from dehydration

Cost

Liraglutide: $1,200-$1,400/month without insurance. semaglutide: $900-$1,400/month without insurance for most agents.

Insurance coverage and manufacturer programs change the relative cost picture significantly. See our individual cost guides for Liraglutide cost and semaglutide cost for the latest numbers.

Which Is Right for You?

The practical decision usually comes down to four factors:

1. What's covered by your insurance? Often the deciding factor
2. What does your prescriber have experience with? Familiarity reduces dosing errors
3. How comfortable are you with injections (or oral dosing if applicable)?
4. What's your tolerance for side effects?

If you and your clinician end up split between Liraglutide and semaglutide, either is a defensible choice in most cases.

Switching Between Them

Switching from Liraglutide to semaglutide (or the reverse) is usually straightforward but should be done with clinician guidance — particularly to align dose escalation and avoid GI side effects from re-titration.

Bottom Line

Head-to-head comparisons are useful but rarely decisive. The bigger swing factors are usually outside the comparison itself.

Frequently Asked Questions

Related Reading

• Liraglutide Explained: How It Works and Who It's For
• Liraglutide Side Effects: The Complete List and How to Handle Them
• Real Liraglutide Results: What 6 and 12 Months Actually Look Like
• The Real Liraglutide Price Tag in 2026 — With and Without Insurance
• Dulaglutide Explained: How It Works and Who It's For
• What Is Exenatide? Everything You Should Know Before Starting

Sources

• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.
• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.
• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.

This page is informational only and is not a personalized recommendation. The right choice depends on your individual situation.